Bariatric and metabolic endoscopy: impact on obesity and related comorbidities.
Amit MehtaReem Z SharaihaPublished in: Therapeutic advances in gastrointestinal endoscopy (2021)
The global obesity pandemic is among the most significant public health crises today. Furthermore, obesity remains a major risk factor for many weight-related comorbid conditions including cardiovascular disease, type 2 diabetes mellitus, liver disease, and cancer. Endoscopic bariatric therapies are currently on the rise as a new tool in the fight against the obesity epidemic, offering patients an alternative to more invasive surgery and a more effective option than diet and lifestyle modifications. The aim of this review article is to summarize the current literature regarding endoscopic bariatric therapies and their impact on obesity and its associated metabolic complications.
Keyphrases
- weight loss
- bariatric surgery
- roux en y gastric bypass
- metabolic syndrome
- insulin resistance
- gastric bypass
- cardiovascular disease
- weight gain
- public health
- type diabetes
- glycemic control
- high fat diet induced
- physical activity
- end stage renal disease
- ejection fraction
- minimally invasive
- coronavirus disease
- obese patients
- ultrasound guided
- body mass index
- adipose tissue
- chronic kidney disease
- coronary artery disease
- peritoneal dialysis
- coronary artery bypass
- skeletal muscle
- global health
- papillary thyroid
- patient reported outcomes